Cancer
More young people surviving cancer in England, despite significant economic divide
January 17, 2019Medical Communications, Research and Development Cancer, England, UK, health public health, oncology, young people
Mortality and five year survival rates in a range of different cancers among people aged 13-24 improved in England between …
MSD’s Keytruda boosts overall survival by 31% in advanced oesophageal cancer
January 16, 2019Research and Development Cancer, MSD, keytruda, oesophageal cancer, pharma
MSD has unveiled new Phase 3 data for its blockbuster anti-PD-1 immunotherapy Keytruda (pembrolizumab), showing that the drug succeeded in …
Breast cancer cells can be transformed into fat cells using combination therapy, study shows
January 16, 2019Research and Development Cancer, EMT, breast cancer, cells, oncology, tumours
An innovative cancer treatment can turn malignant breast cancer cells into fat cells, thus preventing the formation of metastases (the …
Tumours with large number of mutations respond better to immunotherapies, study shows
January 15, 2019Manufacturing and Production, Research and Development Cancer, immunotherapy, nature, oncology, research, tumour
Tumours with a large number of DNA mutations are more likely to respond to immunotherapies than cancers with fewer mutations, …
Dutch health minister attacks Novartis over orphan drug price hike
January 15, 2019Manufacturing and Production Cancer, Lutathera, NL, Netherlands, Novartis, oncology
Dutch health minister Bruno Bairns has called for a meeting with Swiss multinational Novartis after the multibillion-dollar firm introduced a …
AstraZeneca hire controversial cancer doc to head new Oncology R&D unit
January 8, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, journal, oncology
The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.The …
Eli Lilly to buy Loxo Oncology in deal worth $8 billion
January 7, 2019Manufacturing and Production Cancer, Eli Lilly, Loxo Oncology, gene therapy, personalised medicine
US firm Eli Lilly & Co today announced a definitive agreement for the acquisition of Connecticut-based company Loxo Oncology in …
Roche’s Genentech inks potential $2bn personalised cancer drug development deal
January 7, 2019Sales and Marketing Adaptive Biotechnologies, Cancer, Genentech, Roche, oncology, pharma
Roche’s Genentech is set to enter into a deal with Adaptive Biotechnologies to bolster its pursuits in the treatment of …
J&J’s Baby powder tested in India and Bangladesh
December 21, 2018Medical Communications Bangladesh, Cancer, India, J&J, JJ, asbestos
Bangladeshi authorities will collect and test samples of Johnson & Johnson’s baby powders for traces of cancer causing asbestos, after …
Merck KGaA hands over CAR-T therapy business to Intrexon in deal worth $175 million
December 20, 2018Business Services, Medical Communications, Sales and Marketing CAR T, CAR-T, Cancer, Germany, Intrexon, Merck KGaA, darmstadt, oncology
German pharma firm Merck KGaA has agreed to hand over its CAR-T therapy business to US company Intrexon in a …
Indian authorities seize J&J Baby Powder in response to Reuters report
December 19, 2018Research and Development Cancer, India, J&J, JJ, asbestos, baby powder, regulation
Indian authorities have seized samples of Johnson & Johnson’s Baby Powder from a factory in Baddi in Northern India, after …
CHMP approve Bristol-Myers Squibb’s Sprycel for paediatric patients with Ph+ ALL
December 17, 2018Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Sprycel, all
New Jersey-based firm Bristol -Myers Squibb today announced that the Committee for Medicinal Products for Human Use (CHMP) of the …
Those living in rural areas less likely to survive cancer, study shows
December 13, 2018Medical Communications, Research and Development Cancer, health, oncology, rural, survival, urban
Those living in rural areas are less likely to survive cancer than their city dwelling counterparts, according to new research …
Tech platform company WuXi Biologics inks deal with cancer specialist Oxford BioTherapeutics worth $450m
December 12, 2018Research and Development Cancer, Oxford Biotherapeutics, WuXi Biologics, alliance, deal, oncology
Clinical stage oncology firm Oxford BioTherapeutics has signed a deal with the open-access biologics technology platform company WuXi Biologics, in …
Pfizer’s palbociclib most commonly used breast cancer drug in clinical trials
December 11, 2018Manufacturing and Production, Sales and Marketing Cancer, breast cancer, clinical trials, global data, oncology
Pfizer’s palbociclib is the most commonly used breast cancer drug in clinical trials, according to analytics firm GlobalData. The drug, …
Latest content
Five Facts about cardiovascular disease
